Unraveling the Role of Tetraspanins in Viral Infections and Potential Therapeutic Strategies
Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 08, 2025 1 month, 4 days, 23 hours, 39 minutes ago
Medical News: Understanding the Significance of Tetraspanins
Tetraspanins are a unique family of membrane proteins that play a crucial role in numerous biological processes, including cell adhesion, signaling, and immune responses. These proteins, characterized by their four transmembrane domains, are now emerging as key players in the complex interactions between viruses and host cells. Researchers from the School of Life Sciences at Northwestern Polytechnical University in China, along with experts from the University of Victoria in Canada, have conducted an extensive study shedding light on how tetraspanins influence viral infections and exploring their potential as therapeutic targets.
.jpg)
The Role of Tetraspanins in Viral Infections
Diagram showing the role of Tspans during virus infection. (1) Tspans on the cell membranes serve as virus-specificreceptors, engaging with proteins on the virus surface. (2) Tspans trigger viral internalization through endocytosis or fusion. (3)Tspans support the disassembly of the virus. In the case of some viruses, the downregulation of CD151 perturbs HPV disassembly. (4)altering Tspans has an impact on virus replication, ultimately resulting in the efficient delivery of viral genomes into the cytoplasm ornucleus. (5) Tspans mediate the assembly of new viral particles within host cells. (6) spatial aggregation of Tspans and viruses assistsin virus maturation. (7) the resulting high concentration of virus envelope components enables efficient budding and release.
How Tetraspanins Influence Viral Infections
This
Medical News report delves into how tetraspanins act as regulators in viral entry, replication, and immune evasion. Certain tetraspanins, such as CD81, CD9, CD63, and CD151, are involved in the infection processes of major human pathogens, including hepatitis C virus (HCV), human immunodeficiency virus (HIV-1), and influenza A virus (IAV). These proteins facilitate or inhibit viral invasion by acting as co-receptors, forming specialized microdomains known as tetraspanin-enriched microdomains (TEMs) that influence viral binding and internalization.
For instance, CD81 is a well-documented host factor for HCV entry. The study highlighted that the HCV envelope glycoproteins E1 and E2 interact directly with CD81 to promote viral fusion and cell invasion. Researchers found that antibodies targeting the extracellular loop of CD81 could effectively block HCV entry, offering a promising therapeutic approach.
Additionally, CD81 was identified as playing a role in HIV-1 and IAV infections, with distinct mechanisms in each case.
Tetraspanins in Viral Entry and Immune Modulation
One of the key discoveries from this study is the dual role of tetraspanins in viral infections. While some tetraspanins facilitate viral entry, others act as barriers. For example, CD81 and CD9 were shown to suppress HIV-1 invasion by reducing cell-to-cell fusion and syncytia formation. In contrast, CD81 was found to enhance influenza A vir
us infection by directing viral particles into specific intracellular compartments for efficient replication.
The study also identified CD63 as a critical factor in HIV-1 replication and release. CD63 interacts with viral core proteins to assist in the final stages of viral assembly, making it an attractive target for therapeutic intervention. Similarly, CD151 was implicated in the nuclear export and assembly of IAV, and its inhibition significantly reduced viral replication.
Targeting Tetraspanins for Antiviral Therapy
Given their involvement in multiple stages of viral infection, tetraspanins present a valuable target for antiviral therapies. The research team explored various strategies to disrupt tetraspanin-virus interactions. One of the most promising approaches involves the use of monoclonal antibodies (mAbs) targeting specific tetraspanins. For example, anti-CD81 antibodies successfully blocked HCV infection, and similar strategies could be applied to other viral pathogens.
Another potential therapeutic avenue is the use of small interfering RNA (siRNA) to knock down tetraspanin expression. The study demonstrated that siRNA-mediated suppression of CD63 reduced HIV-1 replication, while CD151 silencing hindered influenza A virus replication. These findings highlight the potential of gene-targeting therapies in combating viral infections.
Furthermore, researchers investigated the use of recombinant soluble extracellular loops (LELs) of tetraspanins to interfere with viral binding. By introducing soluble LELs of CD81, they were able to competitively inhibit HCV attachment to host cells, significantly reducing infection rates. This approach could be expanded to other viral infections where tetraspanins play a crucial role.
Challenges and Future Directions
While targeting tetraspanins presents a promising antiviral strategy, several challenges remain. One of the main concerns is the potential impact on normal cellular functions, as tetraspanins are involved in essential physiological processes. Therefore, a selective approach that minimizes off-target effects is crucial.
Additionally, the study emphasized the need for further research to understand the precise molecular mechanisms of tetraspanin-virus interactions. Advanced imaging techniques and high-throughput screening methods could help identify more effective inhibitors and refine existing therapies.
Another critical area for future exploration is the role of tetraspanins in emerging and re-emerging viral infections, such as coronaviruses and arboviruses. Understanding how these proteins contribute to viral pathogenesis could pave the way for broad-spectrum antiviral therapies.
Conclusion
The findings from this study underscore the significant role of tetraspanins in viral infections, offering new insights into their potential as therapeutic targets. By modulating tetraspanin activity, researchers may develop innovative strategies to combat a wide range of viral diseases. Whether through monoclonal antibodies, siRNA, or recombinant protein-based approaches, targeting tetraspanins holds great promise for future antiviral interventions.
The study findings were published in the peer-reviewed journal: Virulence.
https://www.tandfonline.com/doi/full/10.1080/21505594.2025.2474188#abstract
For the latest in Virology, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/viral-proteases-can-bind-to-nucleosomal-dna-and-cleave-nuclear-cgas-that-attenuates-type-i-interferon
https://www.thailandmedical.news/news/the-genotoxic-effects-of-viral-infections-including-covid-19
https://www.thailandmedical.news/news/thailand-doctors-discover-natural-compounds-that-kill-deadly-viruses-including-sars-cov-2-and-flu-viruses
https://www.thailandmedical.news/pages/thailand_doctors_listings
https://www.thailandmedical.news/pages/thailand_hospital_listings
https://www.thailandmedical.news/articles/hospital-news
Share
Tweet
Share
